Li Fu, Sylwia Wasiak, Laura M. Tsujikawa, Brooke D. Rakai, Stephanie C. Stotz, Norman C. W. Wong, . . . Ewelina Kulikowski. (2022). Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy. Wiley.
Chicago Style (17th ed.) CitationLi Fu, et al. Inhibition of Epigenetic Reader Proteins by Apabetalone Counters Inflammation in Activated Innate Immune Cells from Fabry Disease Patients Receiving Enzyme Replacement Therapy. Wiley, 2022.
MLA (9th ed.) CitationLi Fu, et al. Inhibition of Epigenetic Reader Proteins by Apabetalone Counters Inflammation in Activated Innate Immune Cells from Fabry Disease Patients Receiving Enzyme Replacement Therapy. Wiley, 2022.